The regulatory landscape has been evolving rather rapidly and it can be challenging to keep up. This session will serve as an update on the multitude of regulatory changes, from the EU’s MDR to new IMDRF documents and how FDA is incorporating some of these international convergence initiatives. Gain insights on the most important changes that impact your business for your current products and those still in development.